Growth Metrics

Idexx Laboratories (IDXX) Gains from Investment Securities (2016 - 2026)

Idexx Laboratories has reported Gains from Investment Securities over the past 17 years, most recently at $60000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 33.33% year-over-year to $60000.0; the TTM value through Dec 2025 reached $7.2 million, down 31.26%, while the annual FY2025 figure was $7.2 million, 31.26% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $60000.0 at Idexx Laboratories, down from $85000.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $15.0 million in Q1 2021 and troughed at -$31000.0 in Q2 2021.
  • A 5-year average of $2.7 million and a median of $123500.0 in 2022 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 148.44% in 2021 and later soared 1127.85% in 2025.
  • Year by year, Gains from Investment Securities stood at $61000.0 in 2021, then fell by 11.48% to $54000.0 in 2022, then increased by 25.93% to $68000.0 in 2023, then plummeted by 33.82% to $45000.0 in 2024, then skyrocketed by 33.33% to $60000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for IDXX at $60000.0 in Q4 2025, $85000.0 in Q3 2025, and $970000.0 in Q2 2025.